STAT Therapeutics, Inc
STAT Therapeutics is focused on developing a device for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as opioid overdose, anaphylaxis, and seizures.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Drug-device combination platform for intramuscular emergency medication
A device developed to facilitate immediate, accurate administration of injectable emergency medicines (e.g., opioids antagonists, anti-allergy, anti-epileptic drugs) into the dorsal forearm, enabling use by patients, caregivers, and healthcare professionals in various settings.
Drug-device combination platform for intramuscular emergency medication
A device developed to facilitate immediate, accurate administration of injectable emergency medicines (e.g., opioids antagonists, anti-allergy, anti-epileptic drugs) into the dorsal forearm, enabling use by patients, caregivers, and healthcare professionals in various settings.
Expertise Areas
- Intramuscular drug delivery
- Drug-device combination product development
- Pharmacokinetics
- Clinical study design
Key Technologies
- Mass spectrometry (LC-MS/MS)
- Drug-device combination platforms
- Wearable drug delivery systems
News & Updates
Presented research at the ASCPT 2025 Annual Meeting demonstrating the pharmacokinetics and safety of intramuscular naloxone administered via the dorsal forearm, supporting device development for this application.
Presented research at the ASCPT 2025 Annual Meeting demonstrating the pharmacokinetics and safety of intramuscular naloxone administered via the dorsal forearm, supporting device development for this application.